Stocks · Health care · Pharmaceutical Preparations

CorMedix Inc.

CRMD Clue Score73
United States Fiscal year ends December CIK 0001410098 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Alan W Dunton
30 Dec 2025
Director
Sold after exercise
20,000
$13.00
$260.00K
Joseph Todisco
18 Dec 2025
Chief Executive Officer
Sold after exercise
30,000
$12.00
$360.00K
Janet Dillione
9 Dec 2025
Director
Sold after exercise
34,000
$12.00
$408.00K
Janet Dillione
2 Dec 2025
Director
Sold after exercise
46,657
$10.00
$466.57K
Janet Dillione
24 Nov 2025
Director
Sold after exercise
26,343
$9.93
$261.59K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 5
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,329,768
History held since 1 Apr 2010